Alembic Pharmaceuticals Ltd
CMA Kartik Vasavada is a seasoned finance professional with extensive experience in financial management across multiple sectors, particularly in pharmaceuticals and manufacturing. Since March 2016, Kartik has been serving as the Deputy General Manager of Business Finance at Alembic Pharmaceuticals Limited, where responsibilities include overseeing plant finance, commercial operations, and managing substantial asset and turnover figures for the API Pharma Business. Previously, Kartik held various roles including Finance Controller at Alstom Power, where expertise involved cost analysis, budgeting, and financial management of joint ventures, as well as managerial positions in finance and accounts at Sarabhai Group and K M Swadia & Co. Educational qualifications include an Associate's degree in Cost & Management Accountancy, a Master of Commerce in Advance Accountancy and Finance Management, and a Bachelor of Commerce.
This person is not in any teams
This person is not in any offices
Alembic Pharmaceuticals Ltd
8 followers
Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for Macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The Company offers international and domestic formulations. Under domestic formulation, it offers Branded Formulations and Generic formulations. Its domestic formulation include Roxid, Zofix, Althrocin, Tellzy AH, Revas H, Lactonic, Folinal, Gestofit, Glisen 1/2, Glimser 1/2, Veldrop, Azithral, Brinzemic and Neolap. Its generic formulations include Cetral, Ephedrex CD, Sicor, Worid, Alcephin, Alcizon, Baciclox, Comeba, Furobid, O Win Suspension, O win T, Silomag Gel, Pentab, Aginal AT and Pyremol.